Alibaba reportedly open-sources Damo Radar medical AI model for CT analysis, SCMP Tech reports
Reported by SCMP Tech · not yet confirmed by the company or a second independent outlet. We update this page when it is.
Alibaba's Damo Academy open-sourced Damo Radar, a vision-language model that analyzes contrast-enhanced CT scans to identify nearly 150 abdominal conditions, including cancers, across 18 organs, SCMP Tech reported. The model was released as open source. Availability outside China is not specified in the evidence.
China context
- Original name
- 阿里巴巴
- Outside China
- Not stated in the sources yet
- Claims
- Company-reported; not yet independently evaluated
- For builders
- Developers outside China can access the open-source model to build abdominal CT analysis tools, but must verify licensing terms and data compliance for their region.
- For investors
- Alibaba's open-source medical AI release may intensify competition in healthcare AI, affecting valuations of startups in medical imaging.
Alibaba Group Holding's research arm, Damo Academy, has open-sourced an artificial intelligence model capable of identifying nearly 150 abdominal conditions – including cancers – by reading computed tomography (CT) scans, according to SCMP Tech. The vision-language model, called Damo Radar, was designed to analyse contrast-enhanced CT scans covering 18 abdominal organs and identify a broad range of diseases and other abnormalities, such as malignant tumors. The open-source release marks the latest step in Alibaba's growing medical AI efforts.
Damo Radar is a vision-language model that processes contrast-enhanced CT scans. It covers 18 abdominal organs and identifies nearly 150 conditions, including cancers and other abnormalities. The evidence does not provide benchmark results or independent evaluation; all capability claims are company-reported.
Hospitals and medical AI developers outside China gain access to an open-source model for abdominal CT analysis, potentially reducing the cost of building diagnostic tools. Alibaba's open-source release puts pressure on competitors to match its medical imaging capabilities or differentiate through proprietary data and regulatory approvals.
For Alibaba, open-sourcing Damo Radar can accelerate ecosystem adoption and position its cloud and AI services for healthcare clients. For developers, the model provides a starting point for building abdominal CT analysis applications without training from scratch.
The next verifiable signal is whether Damo Radar is adopted by non-Chinese hospitals or integrated into third-party medical imaging platforms. Another signal is whether Alibaba publishes benchmark results or obtains regulatory clearance for clinical use in specific markets.